Synthesis and in-vitro antibacterial activity of N-piperazinyl quinolone derivatives with 5-chloro-2-thienyl group

Daru

Volumn 16, Issue 3, 2008, Pages 189-195

  Shafiee, A ^a   Haddad, Zahmatkesh M ^b   Mohammadhosseini, N ^a,c   Khalafy, J ^b   Emami, S ^d   Moshafi, M H ^e   Sorkhi, M ^a   Foroumadi, A ^a,e  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b URMIA UNIVERSITY   (Iran)

^c ISLAMIC AZAD UNIVERSITY   (Iran)

^d MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

In vitro antibacterial activity; N substituted piperazinyl quinolones; Oximes; Quinolones; Thiophene derivatives

Indexed keywords

CIPROFLOXACIN; ENOXACIN; KETONE; N [2 (5 CHLOROTHIOPHENYL 2 )ETHTHYL]PIPERAZINYL QUINOLONE; NORFLOXACIN; OXIME DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACILLUS SUBTILIS; DRUG SYNTHESIS; ENTEROCOCCUS FAECALIS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; ROOM TEMPERATURE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 50949112931     PISSN: 15608115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Saubolle MA. Antimicrobial resistance: current status and future direction. Am. J. Rhinol. 2006; 20(6): 667-671.
2. Hooper DC. Fluoroquinolone resistance among Gram-positive cocci. Lancet Infect. Dis. 2002; 2: 530-538.
3. Emami S, Shafiee A, Foroumadi A. Structural features of new Quinolones and relationship to antibacterial activity against Gram-positive bacteria. Mini-Rev. Med. Chem. 2006; 6: 375-386.
4. Anderson, VE, Osherhoff N. Type II topoisomerases as targets for quinolone antibacterials: turning Dr. Jekyll into Mr. Hyde. Curr. Pharm. Des. 2001; 7: 337-353.
5. Hooper DC. Mechanisms of action of antimicrobial: focus on fluoroquinolones. Clin. Infect. Dis. 2001; 32(suppl 1):S9-S15.
6. Shen LL, Baranowski J, Pernet AG. Mechanism of inhibition of DNA gyrase by quinolone antibacterials: specificity and cooperativity of drug binding to DNA. Biochemistry, 1989; 28: 3879-3885.
7. Klopman G, Macina OT, Levinson ME, Rosenkranz HS. Computer automated structure evaluation of quinolone antibacterial agents. Antimicrob. Agents Chemother. 1987; 31: 1831-1840.
8. Foroumadi A, Firoozpour L, Emami S, Mansouri S, Ebrahimabadi AH, Asadipour A, Amini M, Saeid-Adeli N, Shafiee A. Synthesis and antibacterial activity of N-[5-(chlorobenzylthio)-1,3,4-thiadiazol-2-yl] piperazinyl quinolone derivatives., Arch. Pharm. Res. 2007; 30 (2): 138-145.
9. Foroumadi A, Mansouri S, Emami S, Mirzaei J, Sorkhi M, Saeid-Adeli N, Shafiee A. Synthesis and Antibacterial Activity of Nitroaryl Thiadiazole-Levofloxacin Hybrids., Arch. Pharm. Chem. Life Sci. 2006; 339: 621-624.
10. Foroumadi A, Mohammadhosseini N, Emami S, Letafat B, Faramarzi MA, Samadi N, Shafiee A. Synthesis and antibacterial activity of new 7-piperazinyl- quinolones containing a functionalized 2-(furan-3-yl)ethyl. Arch. Pharm. Chem. Life Sci. 2007; 340: 47-52.
11. Foroumadi A, Emami S, Mansouri S, Javidnia A, Saeid-Adeli N, Shirazi FH, Shafiee A. Synthesis and antibacterial activity of levofloxacin derivatives with certain bulky residues on piperazine rings. Eur. J. Med. Chem. 2007; 42: 985-992.
12. Fang KC, Chen YL, Sheu JY, Wang TC, Tzeng CC. Synthesis, antibacterial, and cytotoxic evaluation of certain 7-substituted norfloxacin derivatives, J. Med. Chem. 2000; 43 (20): 3809-3812.
13. Foroumadi A, Emami S, Mehni M, Moshafi M, Shafiee A. Synthesis and antibacterial activity of N-[2-(5-bromothiophen-2-yl)-2-oxoethyl] and N-[(2-(5-bromo thiophen-2-yl)-2-Oximinoethyl] derivatives of piperazinyl quinolones. Bioorg. Med. Chem. Lett. 2005; 15: 4536-4539.
14. th edition, The C. V. Mosby Company: St. Louis. 2002; 235-236.
15. Kreuz KL, Fishkill NY, Hurd CD. Nitrothiophenyl ketones, 1953; US patent 2642440.
16. Buu-Hoi NH. Thiophen series III. Indoles, naphthindoles, pyrrocolines, and pyrimidazoles derived from the thiophene nucleus, Rec. Trav. Chim. 1949; 68: 441-472.
17. Foroumadi A, Oboudiat M, Emami S, Karimollah A, Saghaee L, Moshafi MH, Shafiee A. Synthesis and antibacterial activity of N-[2-[5-(methylthio) thiophen-2-yl]-2-oxoethyl] and N-[2-[5-(methylthio)thio phen-2-yl]-2-(oxyimino)ethyl] piperazinylquinolone derivatives. Bioorg. Med. Chem. 2006; 14: 3421-3427.